Loading...

News

Home / News
The era of medical cannabis: a huge therapeutic potential within the European Union
Labiana | 2 August
Fran Fernández Campos, PhD in Pharmacy and Director of R&D at Labiana Pharmaceuticals Cannabis, more popularly known as marijuana, has
Read More
Labiana ANEMBE
Labiana exhibits at the XXV Anembe International Congress of Bovine Medicine
Labiana | 12 May
This year Anembe returns with strenght as the reference congress for bovine health specialists.             
Read More
Labiana incrementa su facturación en 2022 hasta los 57,85 millones de euros
Artbits | 4 May

Labiana ha hecho público su informe de resultados mostrando un incremento del 1,6% en su facturación en 2022. Apúntate al Webinar.

Read More
ProPet 2022 Labiana
Labiana refuerza su división especializada en pequeños animales y lanzará en IberZoo+Propet un complejo vitamínico para mascotas
Labiana | 14 March

Labiana, el primer laboratorio veterinario español cotizado en Bolsa, ha reforzado su división especializada en pequeños animales.

Read More
Ataxxa, distribuido por Labiana, autorizado para la reducción del riesgo de infección por Leishmania
Labiana | 17 February

Ataxxa, medicamento distribuido por Labiana, autorizado para la reducción del riesgo de infección por Leishmania.

Read More
Tolfelab100ml
LABIANA REFUERZA SU PLAN DE CRECIMIENTO CON LA APROBACIÓN DEL GENÉRICO INYECTABLE VETERINARIO TOLFELAB
Labiana | 15 December

Se trata de un anti-inflamatorio que puede prescribirse como coadyuvante en el tratamiento de enfermedades que cursen con dolor e inflamación en bovino, porcino, perros y gatos. Su principio activo es el ácido tolfenámico

Read More
LABIANA REACHES THE FINAL STAGES OF ITS IPO AND MARKS A MILESTONE IN THE SPANISH VETERINARY INDUSTRY
Labiana | 23 May
Labiana Health S.A. ("Labiana" or the "Group") is an integrated and independent animal and human health platform with international presence,
Read More
LABIANA PHARMACEUTICALS ANNOUNCES ITS NEW MANUFACTURING LINE OF AMPOULE FILLING
Labiana | 22 October
From Labiana Pharmaceuticals we are proud to announce the expansion of our production facilities with a new line for liquid ampoules
Read More
LABIANA IS BACK TO ON-SITE EXHIBITIONS
Labiana | 28 September
After almost 2 years of virtual exhibitions, Labiana team is keen to see you again at the main pharmaceutical and
Read More
LABIANA COLLABORATES IN THE DEVELOPMENT OF A VACCINE AGAINST THE NEW VARIANT OF THE HARE MYXOMATOSIS VIRUS
Labiana | 9 June
Introduction Myxomatosis is a widespread and lethal viral disease of the common rabbit (Oryctolagus cuniculus) caused by the Myxoma virus
Read More